Product NDC: | 51808-201 |
Proprietary Name: | ACD Solution Modified |
Non Proprietary Name: | ACD Solution Modified |
Active Ingredient(s): | 8 mg/mL & nbsp; ACD Solution Modified |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51808-201 |
Labeler Name: | AnazaoHealth Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 20120523 |
Package NDC: | 51808-201-01 |
Package Description: | 10 mL in 1 VIAL (51808-201-01) |
NDC Code | 51808-201-01 |
Proprietary Name | ACD Solution Modified |
Package Description | 10 mL in 1 VIAL (51808-201-01) |
Product NDC | 51808-201 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ACD Solution Modified |
Dosage Form Name | SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20120523 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | AnazaoHealth Corporation |
Substance Name | ANHYDROUS CITRIC ACID |
Strength Number | 8 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |